ARTICLE | Distillery Therapeutics
Inhibiting ZFYVE28 for insulin resistance
December 4, 2023 3:10 PM UTC
Inhibiting the early endosome-localized zinc finger protein ZFYVE28 could help treat insulin resistance by preventing ZFYVE28’s promotion of phosphorylated insulin receptor degradation and inhibition of insulin receptor recycling.
Compared with non-obese individuals, peripheral blood ZFYVE28 gene expression was lower in insulin-sensitive obese patients, but higher in insulin-resistant obese patients. ZFYVE28 mRNA and protein expression were higher in fat samples from insulin-resistant obese patients than in samples from healthy individuals. ...
BCIQ Company Profiles
Chinese Academy of Medical Sciences and Peking Union Medical College